BioStem Technologies, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingNewest
None
No S-3 or F-3 shelf on file in the last 30 months.
$40.0M
Roth Principal Investments, agreement of 2026-09-18. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗
Warrants
The 10-Q filed 2026-08-12 is not read yet.
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-29 | Private placement | 735,296 | $4.08 | $3.0M | 8-K ↗ |